Ihnv g protein for immune stimulation
CA 2498896 C · Owner: Novartis Tiergesundheit Ag · Inventors: Bootland, Linda M.; Simard, Nathalie C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A vaccine comprises a portion of IHNV G protein and a portion of a second protein from a fish pathogen or their respective nucleic acid coding sequences. The presence of the IHNV G protein boosts the immune response to the second protein, resulting in a protective effect against infection by the fish pathogen from which the second protein is derived.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 16, 2003 and granted October 21, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 16, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 16, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.